What To Expect From AngioDynamics Inc (ANGO) Q2 2025 Earnings
AngioDynamics Inc (NASDAQ:ANGO) is set to release its Q2 2025 earnings on Jan 8, 2025. The consensus estimate for Q2 2025 revenue is $70.93 million, and the earnings are expected to come in at -$0.22 per share.
AngioDynamics: Fiscal Q2 Earnings Snapshot
AngioDynamics expects full-year earnings in the range of 34 cents to 38 cents per share, with revenue in the range of $282 million to $288 million. AngioDynamics shares have risen roughly 3% since the beginning of the year. The stock has increased 47% in the last 12 months.
AngioDynamics, Inc. (ANGO) Q2 2025 Earnings Call Transcript
Q2 2025 Earnings Conference Call January 8, 2025 8:00 AM ETCompany ParticipantsJim Clemmer - President and Chief
AZZ: Fiscal Q3 Earnings Snapshot
The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.29 per share. The electrical equipment maker posted revenue of $403.7 million in the period, which also beat Street forecasts.
UniFirst: Fiscal Q1 Earnings Snapshot
(UNF) on Wednesday reported profit of $43.1 million in its fiscal first quarter. The Wilmington, Massachusetts-based company said it had net income of $2.31 per share. Earnings, adjusted for non-recurring costs,
Cal-Maine: Fiscal Q2 Earnings Snapshot
(CALM) on Tuesday reported fiscal second-quarter profit of $219.1 million. The Ridgeland, Mississippi-based company said it had profit of $4.47 per share. The egg producer posted revenue of $954.7 million in the period.
Hosted on MSN2h
AngioDynamics (ANGO) Reports Q2 Loss, Tops Revenue Estimates
AngioDynamics (ANGO) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.05 per share a year ago. These figures are ...
AngioDynamics Inc. Q2 Loss Decreases, Beats Estimates
AngioDynamics Inc. (ANGO) revealed Loss for second quarter that decreased from last year but beat the Street estimates. The ...
AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding ...
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife(TM) System
Attendees will gain insights into the NanoKnife System’s proprietary irreversible electroporation (IRE) technology and how it is poised to become the standard, function-preserving treatment for men ...
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...
Vanguard10d
Michael Ango: Revolutionizing revenue assurance in the FCT
In August 2024, President Bola Ahmed Tinubu appointed Mr. Michael Hadi Ango as the Acting Executive Chairman of the Federal ...
Arise3d
Northern Elders’ Forum Demands Immediate Suspension of Proposed Tax Reform Bills
The Northern Elders’ Forum (NEF) on Saturday, demanded immediate suspension of the proposed Tax Reform Bills. The convener of NEF, Professor Ango Abdullahi, had in a communique issued after the ...